Ping An Biomedical (PASW) Current Deferred Revenue (2024 - 2025)
Ping An Biomedical (PASW) reported Current Deferred Revenue of $9749.0 for Q3 2025, down 95.82% on a YoY basis from $233500.2 in Q3 2024, and down 90.66% quarter-over-quarter from $104412.0 in Q1 2025.
Ping An Biomedical (PASW) Current Deferred Revenue (2024 - 2025) Analysis & Trends
Ping An Biomedical has reported Current Deferred Revenue for 2 years, with the latest figure at $9749.0 in Q3 2025.
- For the quarter ending Q3 2025, Current Deferred Revenue fell 95.82% year-over-year to $9749.0; the trailing twelve-month figure through Sep 2025 stood at $9749.0 (down 95.82% YoY), and the FY2025 full-year result was $9801.0, down 95.8% from the prior year.
- Current Deferred Revenue for Q3 2025 stood at $9749.0, down from $104412.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $233500.2 in Q3 2024, with the low at -$60392.2 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Albany International | 1.99 Bn | 1.87 Bn | 99.79 Mn |
| 2 | Unifi | 73.82 Mn | 45.35 Mn | 9.12 Mn |
| 3 | Ping An Biomedical | 427,306.12 | -4.70 Mn | - |
| 4 | Culp | - | - | 5.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9,748.96 |
| Mar 31, 2025 | 104,412.00 |
| Sep 30, 2024 | 233,500.24 |
| Mar 31, 2024 | -60,392.18 |